Health, Medical & Pharma News - Updated Daily page 139

Fall of Roe v. Wade Has Made Access to Ob/Gyns Tougher in Many States: Report

Ever since the Supreme Court overturned Roe v. Wade in June 2022, even more women have struggled to find reproductive care, a new report warns. have been harmed

Endometriosis Linked to Four-fold Higher Odds for Ovarian Cancer

Women who struggle with endometriosis may be vulnerable to another health danger New research shows they are about four times more likely to develop ovarian can

Herpes Infections Recently Cost $35 Billion Globally

Herpes simplex virus (HSV)-2 and HSV-1 infections and their consequences cost 35 billion globally in 2016, according to a study published online July 2 in BMC G

Large Geographic Variation Seen With Heart Failure Phenotypes

There is substantial geographic variation in patient characteristics, treatment, and outcomes among patients with heart failure with preserved ejection fraction

Postexposure Prophylaxis With Nirmatrelvir-Ritonavir Does Not Cut COVID-19 Infection

Postexposure prophylaxis with nirmatrelvir-ritonavir for five or 10 days does not reduce the risk for symptomatic severe acute respiratory syndrome coronavirus

Air Pollution Exposure Tied to New Psoriasis

Long-term exposure to air pollution is associated with the development of new psoriasis, according to a study published online July 16 in JAMA Network Open. Jun

Digital Subtraction Angiography-Guided TDC Performance Superior

The performance of digital subtraction angiography (DSA)-guided tunneled dialysis catheters (TDC) is superior to that of ultrasound-guided TDC in renal replacem

Disparities in Post-Acute Stroke Care Depend on Insurance Status

Insurance-dependent racial and ethnic disparities and regional variations are seen in post-acute service utilization after stroke, according to a study publishe

Ofatumumab Effective for MS Across Racial, Ethnic Subgroups

For patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective than teriflunomide across racial and ethnic subgroups, according to a study p

Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease

For patients with moderate-to-severe Crohn disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic

Pharmaceutical News and Articles